NASDAQ: MEDPMedpace Holdings Inc Stock
$466.79+8.89 (+1.94%)
Updated Jun 9, 2026
MEDP Price
$466.79
Fair Value Price
$643.16
Market Cap
$13.33B
52 Week Low
$294.07
52 Week High
$628.92
P/E
28.78x
P/B
22.28x
P/S
5.1x
PEG
3.12x
Dividend Yield
N/A
Revenue
$2.68B
Earnings
$460.40M
Gross Margin
29.1%
Operating Margin
20.87%
Profit Margin
17.2%
Debt to Equity
2.56
Operating Cash Flow
$739M
Beta
1.22
Next Earnings
Jul 20, 2026
Ex-Dividend
N/A
Next Dividend
N/A
MEDP Overview
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MEDP's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Diagnostic & Research
Industry Rating
C
MEDP
Ranked#21 of 45
Ranked#21 of 45
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $22.75 | A | |
| $135.48 | B | |
| $102.39 | B |
Be the first to know about important MEDP news, forecast changes, insider trades & much more!
MEDP News
Overview
Due Diligence Score
–
Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MEDP scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MEDP ($466.79) is undervalued by 27.42% relative to our estimate of its Fair Value price of $643.16 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MEDP ($466.79) is significantly undervalued by 27.42% relative to our estimate of its Fair Value price of $643.16 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
MEDP ($466.79) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MEDP due diligence checks available for Premium users.
Valuation
MEDP fair value
Fair Value of MEDP stock based on Discounted Cash Flow (DCF)
Price
$466.79
Fair Value
$643.16
Undervalued by
27.42%
MEDP ($466.79) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MEDP ($466.79) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MEDP ($466.79) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MEDP price to earnings (PE)
For valuing profitable companies with steady earnings
Company
28.78x
Industry
17.27x
Market
14.33x
MEDP is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MEDP is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
MEDP price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
22.28x
Industry
3.64x
MEDP is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MEDP price to earnings growth (PEG)
For valuing profitable companies with growth potential
MEDP is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
MEDP's financial health
Profit margin
Revenue
$706.6M
Net Income
$123.9M
Profit Margin
17.5%
MEDP's Earnings (EBIT) of $559.02M... subscribe to Premium to read more.
Interest Coverage Financials
MEDP's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.1B
Liabilities
$1.5B
Debt to equity
2.56
MEDP's short-term liabilities ($1.35B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MEDP's short-term assets ($1.14B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MEDP's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MEDP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$151.8M
Investing
-$6.7M
Financing
$12.7M
MEDP's operating cash flow ($739.18M)... subscribe to Premium to read more.
Debt Coverage Financials
MEDP vs Diagnostic & Research Stocks
Medpace Holdings Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.